Jonathan Jay Mazelsky
At a glance: Jonathan Jay Mazelsky is Chair at Idexx Laboratories (IDXX). Their latest SEC Form 4, filed Nov 5, 2026, reported a sale of $1.4M. On file: 1 purchase line ($101K) and 26 sale lines ($33.0M).
Disclosed holdings: about $57.9M of IDXX stock: 83,803 shares reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 19, 2026 close of $690.95. This counts only IDXX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO, President at Idexx Laboratories Inc /De (IDXX); Chair at Idexx Laboratories Inc /De (IDXX); Director at DENTSPLY SIRONA Inc. (XRAY)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
Jonathan Jay Mazelsky's InsiderPrint
27 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 27 times a year, typically $976K a trade.
- Bump outward: a purchase (1)
- Dent inward: a sale (26)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Strauss ZelnickDirector · STWD · 99% match
- Jeffrey FlugDirector · PNNT · 94% match
- Jamere JacksonCFO · AZO · 94% match
- Satish DhanasekaranCEO, President · KEYS · 94% match
- Jason AryehDirector · LGND · 94% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,945106,998 held (−2%) | $698.26 | $1.4M | -1.0% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 4,075102,923 held (−4%) | $699.33 | $2.8M | -1.2% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,667101,256 held (−2%) | $700.33 | $1.2M | -1.3% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 4,54096,716 held (−4%) | $701.36 | $3.2M | -1.5% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,13694,580 held (−2%) | $702.21 | $1.5M | -1.6% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 3,95090,630 held (−4%) | $703.45 | $2.8M | -1.8% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 24090,390 held (−0%) | $705.59 | $169K | -2.1% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 84089,550 held (−1%) | $707.00 | $594K | -2.3% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,84087,710 held (−2%) | $707.84 | $1.3M | -2.4% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,30086,410 held (−1%) | $709.00 | $922K | -2.5% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,50184,909 held (−2%) | $710.12 | $1.1M | -2.7% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 77584,134 held (−1%) | $711.31 | $551K | -2.9% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 33183,803 held (−0%) | $711.95 | $236K | -2.9% |
| Jun 18SEC | XRAYDENTSPLY SIRONA Inc.First buy | Buy | 10,00061,669 held (+19%) | $10.14 | $101K | -17.5% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,281105,651 held (−1%) | $650.67 | $834K | +6.2% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,095104,556 held (−1%) | $651.49 | $713K | +6.1% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,669102,887 held (−2%) | $652.49 | $1.1M | +5.9% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,171101,716 held (−1%) | $653.68 | $765K | +5.7% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,111100,605 held (−1%) | $654.63 | $727K | +5.5% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,48899,117 held (−1%) | $655.85 | $976K | +5.4% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,34397,774 held (−1%) | $656.85 | $882K | +5.2% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,86094,914 held (−3%) | $657.84 | $1.9M | +5.0% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 3,66091,254 held (−4%) | $658.92 | $2.4M | +4.9% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,85988,395 held (−3%) | $659.75 | $1.9M | +4.7% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,20087,195 held (−1%) | $661.10 | $793K | +4.5% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,00086,195 held (−1%) | $662.16 | $662K | +4.3% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,58983,606 held (−3%) | $663.04 | $1.7M | +4.2% |
- Buy
Director Jonathan Jay Mazelsky bought $101K of XRAY at $10.14 — first open-market purchase in our records.
Follow Jonathan Jay Mazelsky
Get one email when Jonathan Jay Mazelsky files a new purchase or sale. Free.
At most one email a day about Jonathan Jay Mazelsky, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.